Veru Announces Acceptance of Two Abstracts for Presentation at the 39th Miami Breast Cancer…
MIAMI, March 04, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of breast and prostate cancers, today announced that two abstracts…